Add to Calendar 07/25/2017 11:30 07/25/2017 13:30 America/Los_Angeles Bay Area Medical Device Lunch-n-Learn As more companies develop combination products, it is critical to understand the regulatory interface between biopharmaceuticals and medical devices/diagnostics when planning for product development and market entry.  Strategic plans can be greatly impacted by the lack of clarity regarding the primary mode of action.  Minnie Baylor-Henry will share insights as to how best to navigate the regulatory landscape of these combination products and prepare for a pathway to success.  Biocom afarver@biocom.org false MM/DD/YYYY